Full Text
MSR44 Balancing Power and Interpretation: Responder Analysis vs. Mean Differences for PRO Endpoints in Oncology Clinical Trials

Abstract

Authors

Hannah Fairbanks Emma C. Martin Rachael Lawrance

Back to Volume 28, Supplemental Issue 12S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×